Septerna, Inc. - SEPN
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Chief Medical Officer | A | A | 275,000.0 | 0.0 | 0.0 | 275,000.0 | View | |
| Sep 03, 2026 | SVP, Drug Discovery | M | D | 3,333.0 | 0.0 | 0.0 | 9,085.0 | View | |
| Sep 03, 2026 | SVP, Drug Discovery | S | D | 3,333.0 | 37.8271 | 126,077.72 | 96,412.0 | View | |
| Sep 03, 2026 | SVP, Drug Discovery | M | A | 3,333.0 | 2.76 | 9,199.08 | 99,745.0 | View | |
| Aug 14, 2026 | — | S | D | 746,500.0 | 42.5 | 31,726,250.0 | 725,443.0 | View | |
| Aug 14, 2026 | — | S | D | 746,500.0 | 42.5 | 31,726,250.0 | 4,777,415.0 | View | |
| Aug 14, 2026 | — | S | A | 141.0 | 51.08 | 7,202.28 | 6,068,391.0 | View | |
| Aug 14, 2026 | — | S | A | 147,059.0 | 50.27 | 7,392,655.93 | 6,068,532.0 | View | |
| Aug 13, 2026 | President and COO | M | D | 6,319.0 | 0.0 | 0.0 | 82,332.0 | View | |
| Aug 13, 2026 | President and COO | M | D | 18,681.0 | 0.0 | 0.0 | 62,230.0 | View | |
| Aug 13, 2026 | President and COO | S | D | 25,000.0 | 44.0 | 1,100,000.0 | 174,209.0 | View | |
| Aug 13, 2026 | President and COO | M | A | 6,319.0 | 2.76 | 17,440.44 | 199,209.0 | View | |
| Aug 13, 2026 | President and COO | M | A | 18,681.0 | 6.81 | 127,217.61 | 192,890.0 | View | |
| Aug 05, 2026 | SVP, Drug Discovery | M | D | 1,518.0 | 0.0 | 0.0 | 12,418.0 | View | |
| Aug 05, 2026 | SVP, Drug Discovery | M | D | 1,816.0 | 0.0 | 0.0 | 5,227.0 | View | |
| Aug 05, 2026 | SVP, Drug Discovery | S | D | 2,334.0 | 34.6805 | 80,944.29 | 96,412.0 | View | |
| Aug 05, 2026 | SVP, Drug Discovery | S | D | 1,000.0 | 33.9756 | 33,975.6 | 98,746.0 | View | |
| Aug 05, 2026 | SVP, Drug Discovery | M | A | 1,518.0 | 2.76 | 4,189.68 | 99,746.0 | View | |
| Aug 05, 2026 | SVP, Drug Discovery | M | A | 1,816.0 | 2.76 | 5,012.16 | 98,228.0 | View | |
| Jul 17, 2026 | President and COO | M | D | 4,000.0 | 0.0 | 0.0 | 80,911.0 | View | |
| Jul 17, 2026 | President and COO | S | D | 4,000.0 | 33.9935 | 135,974.0 | 174,209.0 | View | |
| Jul 17, 2026 | President and COO | M | A | 4,000.0 | 6.81 | 27,240.0 | 178,209.0 | View | |
| Jul 02, 2026 | SVP, Drug Discovery | M | D | 3,333.0 | 0.0 | 0.0 | 7,043.0 | View | |
| Jul 02, 2026 | SVP, Drug Discovery | S | D | 1,233.0 | 34.8141 | 42,925.79 | 96,412.0 | View | |
| Jul 02, 2026 | SVP, Drug Discovery | S | D | 2,100.0 | 34.0964 | 71,602.44 | 97,645.0 | View | |
| Jul 02, 2026 | SVP, Drug Discovery | M | A | 3,333.0 | 2.76 | 9,199.08 | 99,745.0 | View | |
| Jun 30, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 30, 2026 | Chief People Officer | M | D | 2,178.0 | 0.0 | 0.0 | 20,865.0 | View | |
| Jun 30, 2026 | Chief People Officer | S | D | 2,178.0 | 35.18 | 76,622.04 | 793.0 | View | |
| Jun 30, 2026 | Chief People Officer | M | A | 2,178.0 | 6.81 | 14,832.18 | 2,971.0 | View | |
| Jun 30, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 30, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 30, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 30, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 30, 2026 | — | A | A | 11,260.0 | 0.0 | 0.0 | 11,260.0 | View | |
| Jun 30, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 30, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 24, 2026 | SVP, Drug Discovery | M | D | 4,471.0 | 0.0 | 0.0 | 25,529.0 | View | |
| Jun 24, 2026 | SVP, Drug Discovery | M | D | 10,529.0 | 0.0 | 0.0 | 10,376.0 | View | |
| Jun 24, 2026 | SVP, Drug Discovery | S | D | 7,000.0 | 35.9687 | 251,780.9 | 96,412.0 | View | |
| Jun 24, 2026 | SVP, Drug Discovery | S | D | 8,000.0 | 35.1001 | 280,800.8 | 103,412.0 | View | |
| Jun 24, 2026 | SVP, Drug Discovery | M | A | 4,471.0 | 11.7 | 52,310.7 | 111,412.0 | View | |
| Jun 24, 2026 | SVP, Drug Discovery | M | A | 10,529.0 | 2.76 | 29,060.04 | 106,941.0 | View | |
| Jun 16, 2026 | Chief People Officer | M | D | 6,250.0 | 0.0 | 0.0 | 23,750.0 | View | |
| Jun 16, 2026 | Chief People Officer | S | D | 6,250.0 | 35.0759 | 219,224.38 | 793.0 | View | |
| Jun 16, 2026 | Chief People Officer | M | A | 6,250.0 | 11.7 | 73,125.0 | 7,043.0 | View | |
| Jun 03, 2026 | Chief People Officer | M | D | 637.0 | 0.0 | 0.0 | 4,464.0 | View | |
| Jun 03, 2026 | Chief People Officer | M | D | 943.0 | 0.0 | 0.0 | 2,517.0 | View | |
| Jun 03, 2026 | Chief People Officer | M | D | 4,355.0 | 0.0 | 0.0 | 11,614.0 | View | |
| Jun 03, 2026 | Chief People Officer | S | D | 2,889.0 | 29.6629 | 85,696.12 | 793.0 | View | |
| Jun 03, 2026 | Chief People Officer | S | D | 1,346.0 | 28.7928 | 38,755.11 | 3,682.0 | View | |
| Jun 03, 2026 | Chief People Officer | S | D | 1,700.0 | 27.7831 | 47,231.27 | 5,028.0 | View | |
| Jun 03, 2026 | Chief People Officer | M | A | 637.0 | 2.76 | 1,758.12 | 6,728.0 | View | |
| Jun 03, 2026 | Chief People Officer | M | A | 943.0 | 2.76 | 2,602.68 | 6,091.0 | View | |
| Jun 03, 2026 | Chief People Officer | M | A | 4,355.0 | 1.55 | 6,750.25 | 5,148.0 | View | |
| May 28, 2026 | Chief People Officer | M | D | 11,798.0 | 0.0 | 0.0 | 23,043.0 | View | |
| May 28, 2026 | Chief People Officer | S | D | 11,798.0 | 30.0607 | 354,656.14 | 793.0 | View | |
| May 28, 2026 | Chief People Officer | M | A | 11,798.0 | 6.81 | 80,344.38 | 12,591.0 | View | |
| Apr 17, 2026 | President and COO | M | D | 4,000.0 | 0.0 | 0.0 | 84,911.0 | View | |
| Apr 17, 2026 | President and COO | S | D | 326.0 | 25.8623 | 8,431.11 | 174,209.0 | View | |
| Apr 17, 2026 | President and COO | S | D | 1,101.0 | 25.2394 | 27,788.58 | 174,535.0 | View | |
| Apr 17, 2026 | President and COO | S | D | 2,573.0 | 23.7558 | 61,123.67 | 175,636.0 | View | |
| Apr 17, 2026 | President and COO | M | A | 4,000.0 | 6.81 | 27,240.0 | 178,209.0 | View |